ConductScience.org, home

Paper · 2843547

Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture.

Olwin BB and 1 other. J Cell Biol, 1988. Cited by 189 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. Papers, record 2843547. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2843547

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture.
PubMed
Journal
J Cell Biol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
189
iCite
Relative citation ratio, by iCite
3.9
iCite
Revised in PubMed
2019-05-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Olwin BBB B
2Hauschka SDS D

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErbB ReceptorsMajor topic
MusclesMajor topic
Receptors, Cell SurfaceMajor topic
Animals
Autoradiography
Cell Differentiation
Cell Division
Cell Line
Kinetics
Mice
Mitosis
Muscle, Smooth
Phenotype
Receptors, Fibroblast Growth Factor

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AM 18860NIADDK NIH HHSUnited StatesR01AM018860PubMed and NIH

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,022,285Type beta transforming growth factor is an inhibitor of myogenic differentiation.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3022285PubMed
23,013,291Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts.Biochemistry1986https://conductscience.org/library/papers/3013291PubMed
33,465,734Regulation of myogenic differentiation by type beta transforming growth factor.J Cell Biol1986https://conductscience.org/library/papers/3465734PubMed
43,470,794Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3470794PubMed
52,434,094Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response.Biochem Biophys Res Commun1987https://conductscience.org/library/papers/2434094PubMed
62,431,278Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype.Mol Cell Biol1986https://conductscience.org/library/papers/2431278PubMed
73,624,312Heterokaryon analysis of muscle differentiation: regulation of the postmitotic state.J Cell Biol1987https://conductscience.org/library/papers/3624312PubMed
83,624,313Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.J Cell Biol1987https://conductscience.org/library/papers/3624313PubMed
92,894,374Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells.J Biol Chem1988https://conductscience.org/library/papers/2894374PubMed
1013,768,451Satellite cell of skeletal muscle fibers.J Biophys Biochem Cytol1961https://conductscience.org/library/papers/13768451PubMed

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.

PMIDTitleJournalYearIn PapersSource
34,984,415A validated mathematical model of FGFR3-mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer.Comput Syst Oncol2021https://conductscience.org/library/papers/34984415PubMed
34,208,436Transdifferentiation of Human Fibroblasts into Skeletal Muscle Cells: Optimization and Assembly into Engineered Tissue Constructs through Biological Ligands.Biology (Basel)2021https://conductscience.org/library/papers/34208436PubMed
33,419,207Upstream Regulator Analysis of Wooden Breast Myopathy Proteomics in Commercial Broilers and Comparison to Feed Efficiency Proteomics in Pedigree Male Broilers.Foods2021https://conductscience.org/library/papers/33419207PubMed
30,713,094EGFR-Aurka Signaling Rescues Polarity and Regeneration Defects in Dystrophin-Deficient Muscle Stem Cells by Increasing Asymmetric Divisions.Cell Stem Cell2019https://conductscience.org/library/papers/30713094PubMed
28,900,247Effects of protease-treated royal jelly on muscle strength in elderly nursing home residents: A randomized, double-blind, placebo-controlled, dose-response study.Sci Rep2017https://conductscience.org/library/papers/28900247PubMed
26,052,220Proliferative Dynamics and the Role of FGF2 During Myogenesis of Rat Satellite Cells on Isolated Fibers.Basic Appl Myol1997https://conductscience.org/library/papers/26052220PubMed
25,580,445Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells.Mol Ther Methods Clin Dev2014https://conductscience.org/library/papers/25580445PubMed
25,078,264Transcriptional down-regulation of epidermal growth factor (EGF) receptors by nerve growth factor (NGF) in PC12 cells.J Mol Neurosci2014https://conductscience.org/library/papers/25078264PubMed
23,967,242Epidermal growth factor receptor down-regulation triggers human myoblast differentiation.PLoS One2013https://conductscience.org/library/papers/23967242PubMed
23,569,208Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein.J Biol Chem2013https://conductscience.org/library/papers/23569208PubMed

1 to 10 of 38

See all 38 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2843547

GET https://conductscience.org/api/papers/v1/2843547/references?page=2